Global Cannabis Applications (APP.C) entered into a memorandum of understanding today to supply Efixii QR codes for retail packaging of Europe’s largest CBD producer, CBD Agrocasa, according to a…
February 26, 2021
Revive Therapeutics (RVV.C) provided an update on their Phase 3 clinical trial for bucillamine for COVID-19 today. Primarily, the update’s about funding and more specifically their recent $23 million…
Most people have recognized that the businesses in the list below are the top investments of the last decade or so. To be honest I’ve noticed so many new…
Core One Labs (COOL.C) reported today that they’re ready to start biosynthetic production trials with psilocybin, according to a press release. The company’s Victoria-based subsidiary, Vocan Biotechnologies, finished developing…
For a year, naysayers have dismissed the early stage shroom boom as being a pumpy bunch of pubco RTOs that won’t be able to do business legally for years….
Getting into a stock before management does is basically impossible. As a retail investor, you are waiting on the sidelines while management, institutional investors, and friends & family of…